- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 23.04. | Gilead mounts campaign to close 'HIV gender gap,' calling for greater inclusion of women in UK HIV response | ||
| 23.04. | Sanofi, Novartis CEOs lambast EU price control as Trump reportedly weighs drug cost parity with other nations | ||
| 23.04. | With new trial win, Akeso bispecific shows prior success against Keytruda is no 'fluke' | ||
| 23.04. | Coherus loses commercial chief amid exit from biosimilar space | ||
| 23.04. | Bristol Myers' schizophrenia drug Cobenfy stumbles as adjunctive treatment, denting blockbuster plan | ||
| 23.04. | FDA asks Novavax for post-marketing data pledge amid stalled COVID shot review | ||
| 22.04. | 2 years after leaving PhRMA, AstraZeneca opts back in | ||
| 22.04. | Roche to swell US footprint with sweeping $50B investment, furthering pharma's onshoring push | ||
| 22.04. | Galderma, seeking to build $2B product, starts DTC campaign for eczema drug across TV, digital | ||
| 22.04. | Amid industry's onshoring push, Regeneron taps Fujifilm Diosynth for $3B, 10-year commercial manufacturing team-up | ||
| 22.04. | Facing added pressure from Eli Lilly, Novo Nordisk submits for FDA approval of oral GLP-1 obesity drug | ||
| 21.04. | Gilead's Trodelvy-Keytruda proposal hits goal in first-line triple-negative breast cancer | ||
| 21.04. | Meribel makes CDMO debut after series of acquisitions in Europe | ||
| 21.04. | Top leaders at FDA marketing overseer resign, potentially teeing up RFK Jr.'s promised drug ad ban: report | ||
| 21.04. | Amneal recalls 2 lots of hospital anesthetic over plastic contamination fears | ||
| 21.04. | AstraZeneca, Daiichi say Enhertu delivers 'highly statistically significant' efficacy in first-line breast cancer | ||
| 21.04. | FDA rejection of extended dosing interval is another piece of bad news for Regeneron's Eylea HD | ||
| 18.04. | Sanofi, Regeneron score their 7th indication for Dupixent with FDA nod to treat hives condition | ||
| 18.04. | RFK Jr.'s FDA staff cuts claimed key user fee negotiators, threatening renewal talks with pharma: Reuters | ||
| 18.04. | FDA moves to block biopharma employees from serving on advisory committees | ||
| 18.04. | Navigating Trump's tariffs for pharma | ||
| 18.04. | Fierce Pharma Asia-The latest on Trump's tariffs; Leqembi's EU approval; Kyowa Kirin's biologics plant | ||
| 17.04. | Ligand's Pelthos unit joins forces with Channel Therapeutics in merger centered on launch of molluscum gel Zelsuvmi | ||
| 17.04. | Eli Lilly is overtaking Novo Nordisk in the diabetes, obesity market: BMO analysts | ||
| 17.04. | Recently departed CBER director warns FDA staff cuts could upend drug review timelines as early as next year: BMO |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .